|
|
Volumn 57, Issue 21, 2000, Pages
|
|
FDA approves new protease inhibitor for HIV infection
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CYTOCHROME P450 3A;
LAMIVUDINE;
LOPINAVIR;
NELFINAVIR;
NEW DRUG;
PROTEINASE INHIBITOR;
RITONAVIR;
STAVUDINE;
DIARRHEA;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG FORMULATION;
DRUG MARKETING;
DRUG METABOLISM;
DRUG MIXTURE;
FOOD AND DRUG ADMINISTRATION;
HEADACHE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NAUSEA;
NOTE;
PRIORITY JOURNAL;
|
|
EID: 0034331884
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/57.21.1942 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|